Glioma-associated oncogene homolog 1 in breast invasive carcinoma: a comprehensive bioinformatic analysis and experimental validation
Our study underscores the critical role of GLI1 in BRCA, both as a potential tumor suppressor and an immune regulator. The association between GLI1 expression and favorable prognosis suggests its potential as a prognostic biomarker and immunotherapeutic target in BRCA.
Authors
- Bo Zhao (ORCID: https://orcid.org/0000-0002-8612-5597)
- Fuqing Ji (ORCID: https://orcid.org/0009-0008-1821-8530)
- He Wu (ORCID: https://orcid.org/0009-0002-3281-444X)
- Ye Cheng
- Yonggang Lv (ORCID: https://orcid.org/0000-0003-3966-8975)
- Jie Liu (ORCID: https://orcid.org/0000-0003-3307-1975)
- Jianru Xiao (ORCID: https://orcid.org/0000-0003-1547-851X)
- Teng Qi (ORCID: https://orcid.org/0009-0002-8687-0682)
- Yujie Hu (ORCID: https://orcid.org/0000-0003-3369-5278)
- Junhao Wan
Institutions
- Northwest University (CN)
Publication Details
- Journal
- Frontiers in Cell and Developmental Biology
- Published
- 2024-10-17
- DOI
- https://doi.org/10.3389/fcell.2024.1478478
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85